Carbios is dedicated to the development of industrial bioprocesses for the biorecycling and biodegradation of plastic polymers.
Carbios has developed an enzyme capable of degrading 97% of PET polymers in 16 hours and successfully produced the first ever PET bottles from 100% recycled plastic waste using its breakthrough technology, with the same quality as virgin PET originating from petroleum sources.
In April 2020, Carbios’s PET technology made the front cover of the most prestigious scientific journal Nature.
A partnership with L’Oréal, Nestlé Waters, Suntory Beverage, Pepsico and Carbios was signed in 2019 to create a consortium promoting the PET recycling technology.
Carbios also signed a joint development and exclusive supply agreement with Novozymes, the #1 enzyme producer worldwide.
Proceeds of the Follow-on Offering will be mainly used to finance the second phase and operating expenses of the PET biorecycling demonstration plant currently under construction, and for ongoing corporate and R&D activities.
Carbios is a green chemistry company whose innovations help address the environmental and sustainable development challenges facing manufacturers. Since its creation in 2011 by Truffle Capital, the Company has developed, through biotechnology, two industrial processes that revolutionize the biodegradation and recycling of polymers. These innovations, a world first, optimize the performance and lifecycle of plastics and textiles by exploiting the properties of highly specific enzymes.
Carbios’ economic development model is based on the industrialization and commercialization of its products and/or enzymes, technologies and bioprocesses through license concessions directly or through joint ventures to major industrial players or sectors concerned by the Company’s innovations. As such, Carbios created the joint venture Carbiolice in September 2016, in partnership with Limagrain Ingredients and the SPI fund operated by Bpifrance. This company, of which Carbios has majority control, will exploit the first technology licensed by Carbios by producing enzymatic granules for the production of biodegradable and biobased plastics.
Should you want to know more about this transaction, you can contact one of the team members above
Bryan, Garnier & Co acted as Joint Global Coordinator and Joint Bookrunner on Carbios’ EUR 37m Follow-on Offering. Since Bryan, Garnier & Co successfully raised EUR 14.5m in July 2019, Carbios’ stock price has increased five-fold.
Carbios raised EUR 27m from Tier-1 European cleantech specialists and institutional generalists through a primary offering. In addition, Truffle Capital, historical shareholder and founder of Carbios, sold shares worth EUR 10m in a concomitant secondary offering.
Strong demand allowed to upsize the base deal by 85%, from EUR 20m to EUR 37m.
The transaction was priced at EUR 26.25 a share, representing a discount of 15.3% to the last market closing price (July 22, 2020).
This is another landmark transaction for Bryan, Garnier & Co’s Equity Capital Markets, which demonstrates its unique ability to discover hidden gems, bring them to the attention of specialist investors around the world with an unrivalled commitment to help grow those potential future disrupters.